UBS Group’s Chiasma, Inc. Common Stock CHMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,704
| Closed | -$22K | – | 10747 |
|
|
2021
Q2 | $22K | Sell |
4,704
-7,229
| -61% | -$27.2K | ﹤0.01% | 7264 |
|
|
2021
Q1 | $37K | Buy |
11,933
+5,972
| +100% | +$22.9K | ﹤0.01% | 6845 |
|
|
2020
Q4 | $26K | Buy |
+5,961
| New | +$24.8K | ﹤0.01% | 6768 |
|
|
2020
Q3 | – | Sell |
-8,338
| Closed | -$45K | – | 8669 |
|
|
2020
Q2 | $45K | Sell |
8,338
-9,369
| -53% | -$51.6K | ﹤0.01% | 5948 |
|
|
2020
Q1 | $65K | Sell |
17,707
-23,871
| -57% | -$106K | ﹤0.01% | 5619 |
|
|
2019
Q4 | $206K | Buy |
41,578
+12,940
| +45% | +$67.4K | ﹤0.01% | 5595 |
|
|
2019
Q3 | $142K | Buy |
28,638
+22,077
| +336% | +$125K | ﹤0.01% | 5528 |
|
|
2019
Q2 | $49K | Buy |
6,561
+4,938
| +304% | +$32.4K | ﹤0.01% | 5951 |
|
|
2019
Q1 | $8K | Buy |
+1,623
| New | +$7.15K | ﹤0.01% | 6974 |
|
|
2018
Q4 | – | Sell |
-5,856
| Closed | -$21K | – | 8458 |
|
|
2018
Q3 | $21K | Buy |
+5,856
| New | +$12.3K | ﹤0.01% | 6780 |
|
|
2018
Q2 | – | Sell |
-1,998
| Closed | -$3K | – | 8380 |
|
|
2018
Q1 | $3K | Buy |
1,998
+300
| +18% | +$476 | ﹤0.01% | 7469 |
|
|
2017
Q4 | $3K | Sell |
1,698
-235
| -12% | -$493 | ﹤0.01% | 7563 |
|
|
2017
Q3 | $5K | Buy |
+1,933
| New | +$3.56K | ﹤0.01% | 7256 |
|
|
2017
Q1 | – | Sell |
-5,315
| Closed | -$10K | – | 8135 |
|
|
2016
Q4 | $10K | Buy |
5,315
+2,205
| +71% | +$5.02K | ﹤0.01% | 6940 |
|
|
2016
Q3 | $9K | Buy |
3,110
+841
| +37% | +$2.31K | ﹤0.01% | 6864 |
|
|
2016
Q2 | $7K | Buy |
+2,269
| New | +$9.99K | ﹤0.01% | 6999 |
|
|
2016
Q1 | – | Sell |
-276
| Closed | -$5K | – | 8405 |
|
|
2015
Q4 | $5K | Sell |
276
-1,401
| -84% | -$30.4K | ﹤0.01% | 7715 |
|
|
2015
Q3 | $33K | Buy |
+1,677
| New | +$41.7K | ﹤0.01% | 6216 |
|
UBS Group's CHMA Position: Q3 2021 in Review
UBS Group sold out of Chiasma, Inc. Common Stock (CHMA) in Q3 2021, closing a stake of 4,704 shares — an estimated $22K sold.
UBS Group first reported a position in CHMA in Q3 2015 and held it in 18 quarters. The position peaked at $206K in Q4 2019. 0 funds tracked by Wall St. Rank hold CHMA as of Q3 2021.
- UBS Group reported no remaining Chiasma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
- UBS Group sold 4,704 Chiasma, Inc. Common Stock shares in Q3 2021, an estimated $22K.
- UBS Group first reported a position in Chiasma, Inc. Common Stock in Q3 2015 and held it in 18 quarters.
- UBS Group's Chiasma, Inc. Common Stock position peaked at $206K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Chiasma, Inc. Common Stock as of Q3 2021.
Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.